Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
CC transcript
|
|
Molecular Insight Pharmaceuticals, Inc. (MIPI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/10/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/09/2011 |
SC 13D/A
| Taconic Capital Advisors LP has filed a Schedule 13D for ) INFORMATION TO BE INCLUDED IN STATEMENTS FILED § 240.13d-1 § 240. Molecular Insight Pharmaceuticals, Inc. |
| 03/09/2011 |
SC 13D/A
| McDonnell Loan Opportunity Ltd. has filed a Schedule 13D for Schedule 13D WASHINGTON, DC 20549 SCHEDULE 13D [Rule 13d-101] INFORMATION TO BE INCLUDED IN STATEMENTS FILED § 240.13d-1 § 240. Molecular Insight Pharmaceuticals, Inc. |
| 03/09/2011 |
SC 13D/A
| Molecular Insight Pharmaceuticals, Inc. has filed a Schedule 13D for ) INFORMATION TO BE INCLUDED IN STATEMENTS FILED § 240.13d-1 § 240. Molecular Insight Pharmaceuticals, Inc. |
| 03/09/2011 |
SC 13D/A
| Molecular Insight Pharmaceuticals, Inc. has filed a Schedule 13D for ) INFORMATION TO BE INCLUDED IN STATEMENTS FILED § 240.13d-1 § 240. Molecular Insight Pharmaceuticals, Inc. |
| 01/12/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 01/12/2011 |
SC 13D/A
| Molecular Insight Pharmaceuticals, Inc. has filed a Schedule 13D for ) INFORMATION TO BE INCLUDED IN STATEMENTS FILED § 240.13d-1 § 240. Molecular Insight Pharmaceuticals, Inc. |
| 01/12/2011 |
SC 13D/A
| Taconic Capital Advisors LP has filed a Schedule 13D for ) INFORMATION TO BE INCLUDED IN STATEMENTS FILED § 240.13d-1 § 240. Molecular Insight Pharmaceuticals, Inc. |
| 01/12/2011 |
SC 13D/A
| McDonnell Loan Opportunity Ltd. has filed a Schedule 13D for Schedule 13D Washington, DC 20549 SCHEDULE 13D [Rule 13d-101] INFORMATION TO BE INCLUDED IN STATEMENTS FILED § 240.13d-1 § 240. Molecular Insight Pharmaceuticals, Inc. |
| 01/11/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 08/30/2010 |
SC 13D/A
| Barlow David S reports a 19.9% stake in MOLECULAR INSIGHT PHARMACEUTICALS, INC. |
| 08/13/2010 |
SC 13D/A
| Barlow David S reports a 29.8% stake in MOLECULAR INSIGHT PHARMACEUTICALS, INC. |
| 02/10/2009 |
SC 13D/A
| Barlow David S has filed a Schedule 13D for MOLECULAR INSIGHT PHARMACEUTICALS, INC. |
|
|